PAR:BIM
bioMérieux S.A. · PAR · Healthcare · EUR · FY for 2025
Figures on this page computed 2026-11-08 12:38 UTC
Last close
n/aEUR
Market data
We are not showing closes for this listing. A line drawn through points we do not hold would look exactly like a listing that did not move.
27.7xP/E
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- computed
- Computed from the filing for 2025
10.6%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
9.8%Net margin
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
11.1%FCF margin
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
0.11Debt/equity
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
1.0%Dividend yield
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- computed
Growth is the furthest below its sector's middle: 0.33 against 0.47 on the market's range.
Five bars, one line
lens 7 of 9Each against its own average
4 of 5 readExcept where said otherwise: Computed from the filing for 2025
- Sales1.30x
Its own average over 10 years, 3.13B.
- Profit1.11x
Its own average over 10 years, 359.2M.
- Free cash flow1.83x
Its own average over 10 years, 247.9M.
- Debt0.91x
Its own average over 10 years, 508.8M.
- Pricen/a
Its own average over 0 years. Market data
Free cash flow is furthest from its own average, at 1.83 times.
The filed years, as a table
10Each line is 100 at 2016-12-31, the first year we hold.
| Filed year | Sales | Profit | Shares in issue |
|---|---|---|---|
| 2016-12-31 | 100.0 | 100.0 | 100.0 |
| 2017-12-31 | 108.8 | 132.9 | 100.1 |
| 2018-12-31 | 115.1 | 143.3 | 100.1 |
| 2019-12-31 | 127.2 | 152.3 | 100.3 |
| 2020-12-31 | 148.3 | 225.8 | 100.3 |
| 2021-12-31 | 160.5 | 335.6 | 100.5 |
| 2022-12-31 | 170.6 | 252.6 | 100.1 |
| 2023-12-31 | 174.7 | 199.7 | 100.4 |
| 2024-12-31 | 189.2 | 241.3 | 100.3 |
| 2025-12-31 | 193.5 | 221.9 | 100.6 |
How sales was got
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- EUR
How profit was got
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- EUR
How shares in issue was got
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- EUR
Figures behind the shape
Growth
5.5%faster is higher, placed against 4,950 companies as of 2026-11-07
Five-year revenue growth rate5.5%
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- computed
Five-year EPS growth rate-0.3%
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- computed
One-year change in net income-8.0%
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- computed
Returns on capital
10.6%higher is higher, placed against 5,089 companies as of 2026-11-07
Return on invested capital10.6%
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
Return on equity9.7%
Net Income / Shareholders' Equity x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
Return on assets7.1%
Net Income / Total Assets x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
Margins
52.6%wider is higher, placed against 3,412 companies as of 2026-11-07
Gross margin52.6%
Gross Profit / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
Operating margin13.8%
Operating Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
Net margin9.8%
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
Free cash flow margin11.1%
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
Price
27.7xcheaper is higher, placed against 4,362 companies as of 2026-11-07
Price to earnings27.7x
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- computed
- Computed from the filing for 2025
Price to book2.7x
Price / Book Value per Share, where BVPS = Shareholders' Equity / Diluted Shares
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- computed
- Computed from the filing for 2025
- computed
- Computed from the filing for 2025
EV to EBITDA11.0x
Enterprise Value / EBITDA, where EV = Market Cap + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- computed
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
Price to sales ratio2.7x
Market Cap / Revenue, where Market Cap = Price x Diluted Shares
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- computed
- Computed from the filing for 2025
- Computed from the filing for 2025
Safety
0.11safer is higher, placed against 3,227 companies as of 2026-11-07
Debt to equity0.11
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
Current ratio2.39
Current Assets / Current Liabilities
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
Interest coverage35.5x
Operating Income / Interest Expense
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
Altman Z-Score6.02
1.2 x A + 1.4 x B + 3.3 x C + 0.6 x D + 1.0 x E (A=WC/TA, B=RE/TA, C=EBIT/TA, D=MktCap/TL, E=Rev/TA)
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
What it pays out
1.0%more, and better covered, is higher, placed against 1,091 companies as of 2026-11-07
Dividend yield1.0%
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- computed
Payout ratio26.7%
Common Dividends Paid / Net Income x 100, both from the latest filed fiscal year
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
Dividend cover ratio4.3x
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- computed
Share a finding
A link to the finding, not to you: it carries nothing about your account.